This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1507/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q82416782
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel scientific article published on 05 November 2010 im November 2010 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en payares de 2010 наукова стаття, опублікована в листопаді 2010
p:P577
wds:Q82416782-70B5D4EC-960B-48E7-8EFF-10297043D58C
wdt:P577
2010-11-05T00:00:00Z
p:P2093
wds:Q82416782-C4BB91CB-6411-400B-8266-C88ADF0725D3 wds:Q82416782-A0BFACFC-EA07-44F5-AF45-62D4FF60326C wds:Q82416782-FFE86ACD-5453-4680-A930-DD9AF8B71C9E wds:Q82416782-5EFC87F7-E8C4-4760-AA83-27ECD201512B wds:Q82416782-68156146-62AD-4ABC-BDD1-FA03E410261D wds:Q82416782-04ED2078-3BB4-4B58-B123-95C676814CAD wds:Q82416782-23D0080C-A12A-43E4-986B-9B302A7B3B01
wdt:P2093
Hiroyasu Kaya Takashi Yoshida Kazuhide Ishikura Noriko Iwaki Toshiro Kurokawa Toshio Kahara Rika Usuda
rdfs:label
Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma
skos:prefLabel
Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma
schema:name
Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma
p:P1476
wds:Q82416782-FC672EEC-AB0D-47B8-A140-B4A800F89054
wdt:P1476
Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma
p:P304
wds:Q82416782-4DAE8052-74C0-445F-81D5-FA136C5CC8E9
wdt:P304
7-12
p:P31
wds:Q82416782-B2B35748-A594-409D-AFE0-FE1C910DAE21
wdt:P31
wd:Q13442814
p:P921
wds:Q82416782-7AB96F16-74B7-4BDF-9D96-43D59FAE7359 wds:Q82416782-C3592B0F-AFEE-4ED6-B070-F5AF28A52E0C
wdt:P921
wd:Q591256 wd:Q412323
p:P698
wds:Q82416782-4E345E93-1EA4-49D1-954C-D11CD405802D
wdtn:P698
n5:21068513
wdt:P698
21068513
p:P1433
wds:Q82416782-9C61683F-5A16-4438-8EC4-369866AEFCD4
wdt:P1433
wd:Q5376304
p:P433
wds:Q82416782-6154FB73-E724-417D-8EAE-5E92BFD7EC42
p:P478
wds:Q82416782-60577DA3-7ED4-4007-85D5-0ACDC04594F9
wdt:P433
1
wdt:P478
58
p:P356
wds:Q82416782-5A2DFECD-081D-44DC-AEDF-CCA2A6069770
wdtn:P356
n9:ENDOCRJ.K10E-166
wdt:P356
10.1507/ENDOCRJ.K10E-166